Welcome to our dedicated page for Vireo Growth news (Ticker: VREOF), a resource for investors and traders seeking the latest updates and insights on Vireo Growth stock.
Vireo Growth Inc. (VREOF) generates a steady flow of news driven by its activities in the cannabis industry, including medical and adult-use operations, multi-state expansion, and corporate transactions. As a company that describes itself as a pioneering medical cannabis operator founded in 2014, Vireo uses press releases to communicate developments in its retail footprint, cultivation and production capacity, and strategic initiatives.
Recent news items highlight several key themes. One is geographic expansion and market entry. Vireo announced an Agreement and Plan of Merger to acquire Eaze Inc., a vertically integrated cannabis retailer and delivery technology platform with operations in California, Florida, and Colorado. The company states that this transaction is intended to mark its entry into California and Florida and to strengthen its position in Colorado, with Eaze becoming a wholly owned subsidiary upon closing.
Another recurring theme is M&A and capital structure activity. Vireo has reported entering into agreements to acquire a majority of Schwazze’s senior secured convertible notes, participating in a restructuring support agreement that contemplates an asset sale to a new entity to be majority-owned by Vireo, and negotiating an Asset Purchase Agreement to acquire Colorado dispensary assets from PharmaCann Inc. These announcements detail transaction terms, consideration in subordinate voting shares, and conditions such as regulatory approvals.
Operational updates also feature prominently. Vireo issued a release announcing the launch of adult-use cannabis sales in Minnesota at its Green Goods dispensaries, noting that it dispenses both medical and adult-use products at eight locations in the state. Quarterly earnings releases provide summaries of financial performance, state-by-state revenue, and non-GAAP metrics, accompanied by management commentary on integration of acquisitions and portfolio development.
Investors and observers who follow VREOF news can use this stream of announcements to monitor transaction progress, regulatory milestones, market entries, adult-use launches, litigation resolutions, and financial reporting updates, all of which are documented through Globe Newswire releases and linked SEC filings.
Vireo Growth (VREOF) reported strong financial results for Q4 and full year 2024, achieving record performance metrics. FY2024 revenue reached $99.4 million, marking a 15.4% year-over-year increase excluding discontinued operations. Q4 2024 revenue was $25.0 million, up 3.5% year-over-year but flat sequentially.
The company ended FY2024 with $91.6 million in cash following a successful private placement in December, where investors subscribed for 129,536,874 shares at $0.625 per share, raising approximately $81 million. Q4 results included one-time transaction expenses of $4.2 million related to pending merger transactions.
Additionally, Vireo secured two significant loans through its Minnesota subsidiary: a $11.5 million facility at 10.5% interest for a new indoor cultivation facility, and a $15.0 million commercial loan from Stearns Bank at 9.25% interest.
Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) has announced it will release its fourth quarter and full year 2024 financial results on March 4, 2025, before market opening. The company will host a conference call with investors on the same day at 8:30 a.m. ET (7:30 a.m. CT). Interested parties can join via phone using toll-free number 1-800-715-9871 (US and Canada) or 1-646-307-1963 (International) with conference ID 3718174. A live audio webcast will be available through the company's Investor Relations website.
Vireo Growth has successfully closed an oversubscribed private placement offering, raising US$81 million through the issuance of 129,536,874 Subordinate Voting Shares at US$0.625 per share. The offering price represents a 16.8% premium to the closing share price on OTCQX as of December 27, 2024.
The company plans to utilize the net proceeds for business development, including organic and acquisitive growth investments, working capital, and general corporate purposes. The offering, initially planned for US$75 million, exceeded expectations with oversubscribed demand. Lineage Merchant Partners acted as placement agent, with securities placed through GT Securities.
Vireo Growth Inc. has announced a major expansion through a $75 million equity financing at $0.625 per share and acquisitions of four single-state cannabis operators for approximately $397 million in all-stock transactions. The acquisitions include Proper Brands (Missouri), Deep Roots Harvest (Nevada), WholesomeCo Cannabis (Utah), and The Flowery (Florida).
The combined entity will operate across 7 states with 9 cultivation facilities and 48 dispensaries. The company projects 2024 proforma revenue of $394 million and EBITDA of $94 million. The transactions include the proprietary Arches technology platform for cannabis delivery and analytics.
John Mazarakis has been appointed CEO and Co-Executive Chairman, while Tyson Macdonald becomes CFO. The combined company will have approximately $99 million in cash and $78 million in net debt, with an EBITDA leverage ratio of 0.8x.
Vireo Growth reported Q3 2024 financial results with revenue of $22.4 million (excluding discontinued operations and NY), up 6.2% year-over-year. Operating income reached $3.9 million, though showing a 34.4% decline from Q3 2023. The company secured a $10.0 million convertible debt facility with a 12% interest rate and $0.625 conversion price. Core market performance showed improvements in productivity yields and flower quality, with total flower harvested increasing 32.7% to 4,626 lbs. Same-store sales grew 2.0%, with Maryland up 12.1% while Minnesota declined 3.4%. The company maintains $7.3 million in cash with total current assets of $144.0 million.
Vireo Growth has secured a new $10 million convertible debt facility funded by its senior secured lender. The three-year facility features a 12% cash interest rate, payable monthly, with notes convertible into Subordinate Voting Shares at $0.625. The financing will support capital expenditure, working capital needs, and general corporate purposes, particularly as the company prepares for the launch of adult-use cannabis sales in Minnesota next year. No warrants will be issued with this facility, and the transaction qualifies as exempt from formal valuation and minority shareholder approval requirements under MI 61-101.
Vireo Growth Inc. announced it will release its third quarter 2024 financial results on November 13, 2024, after market close. The company will host a conference call with investors at 4:30 p.m. ET (3:30 p.m. CT) on the same day. Participants can join via phone using toll-free number 1-800-715-9871 (US/Canada) or 1-646-307-1963 (International) with conference ID 3718174. A live audio webcast will be available on the company's Investor Relations website.
Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) announced key leadership changes. Amber Shimpa, a long-time company executive, has been promoted to Chief Executive Officer, effective immediately. Josh Rosen has resigned from his roles as CEO, interim CFO, and Board member to focus on other ventures, but will remain as a consultant. Joe Duxbury has been appointed Interim Chief Financial Officer.
Executive Chairman Kyle Kingsley expressed confidence in Shimpa's leadership, while Shimpa voiced excitement about leading Vireo into the future, particularly with the upcoming launch of adult-use sales in Minnesota. The company also announced the termination of its advisory agreement with Grown Rogue International, Inc., effective September 30, 2024, forfeiting 4.5 million of 8.5 million Grown Rogue warrants received as part of the agreement.
Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) reported strong Q2 2024 results, with revenue of $22.5 million (excluding discontinued operations and NY), up 42.5% year-over-year. The company achieved an operating income of $5.8 million and an EBITDA of $8.1 million. Gross profit margin improved to 54.0%, up 780 basis points from the previous year. Vireo recently extended its credit facility, supporting its CREAM & Fire strategy. The company activated recreational wholesale sales in New York and is preparing for adult-use sales in Minnesota next spring. Vireo also completed a private placement, changed its name from Goodness Growth Holdings, and announced the conversion of outstanding convertible notes by Chicago Atlantic.
Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) has announced significant financial developments:
1. A 30-month extension of its credit agreement with Chicago Atlantic, extending the maturity date to January 29, 2027.
2. Voluntary conversion of all outstanding convertible notes by Chicago Atlantic, resulting in the issuance of approximately 73 million Subordinate Voting Shares.
3. Expected interest expense savings of $2.3 million due to early debt conversion.
4. Issuance of 12.5 million Subordinate Voting Shares to lenders for the credit facility amendment.
These developments aim to strengthen Vireo's financial position and support its growth initiatives, particularly in light of upcoming adult-use sales in Minnesota.